11.02.26c, Percutaneous Left Atrial Appendage Closure Devices for Stroke Prevention in Atrial Fibrillation
Summary
This is a reissue with no substantive changes to Independence Blue Cross policy 11.02.26c regarding percutaneous left atrial appendage (LAA) closure devices for stroke prevention in atrial fibrillation. The policy continues to cover FDA-approved devices (Watchman and Amplatzer Amulet) when specific stroke risk, bleeding risk, and clinical criteria are met. No new billing codes, coverage modifications, or documentation requirements have been introduced in this reissue.
Get alerts when payers change rules like this one
We check Independence Blue Cross and other payers every day and email you when a change matches your specialty and state.